EPR and 51V NMR studies of prospective anti-diabetic bis(3-hydroxy-4-pyridinonato)oxidovanadium(iv) complexes in aqueous solution and liposome suspensions-Reference-Cited by-同舟云学术

EPR and 51V NMR studies of prospective anti-diabetic bis(3-hydroxy-4-pyridinonato)oxidovanadium(iv) complexes in aqueous solution and liposome suspensions

Published:2018 Issue:10 Volume:42 Page:8088-8097
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Ferreira S.¹²³⁴⁵,Leite A.¹⁶⁷³⁸^ORCID,Moniz T.¹⁶⁷³⁸^ORCID,Andrade M.⁹¹⁰¹¹⁵,Amaral L.¹²⁶⁷³⁸,de Castro B.¹⁶⁷³⁸,Rangel M.¹²³⁴⁵^ORCID

Affiliation:

1. REQUIMTE-LAQV

2. Instituto de Ciências Biomédicas de Abel Salazar

3. Universidade do Porto

4. 4050-313 Porto

5. Portugal

6. Departamento de Química e Bioquímica

7. Faculdade de Ciências

8. 40169-007 Porto

9. CEMUP

10. Centro de Materiais da Universidade do Porto

11. 4169-007 Porto

12. REQUIMTE-UCIBIO

Abstract

EPR/⁵¹V-NMR parallel studies of [VO(3,4-HPO)₂] complexes in MOPS buffer and POPC liposome suspensions provide information regarding solvents for oral administration.

Funder

Fundação para a Ciência e a Tecnologia

European Regional Development Fund

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2018/NJ/C7NJ04678B

Reference32 articles.

1. WHO Global report on diabetes, 2016, accessed 16th November, 2017, http://www.who.int/diabetes/global-report/en/

2. A New Concept: The Use of Vanadium Complexes in the Treatment of Diabetes Mellitus